When diagnosing Ewing sarcoma of the lung, the central role lies in distinguishing the histological findings of ES from its mimics, as well as identifying essential IHC markers such as CD99, FLI1, and NKX2.2. Here, NKX2-2 is linked to Ewing sarcoma.